UTI Healthcare Reg Gr
as of 26 May 2026, 16:59 PM
Invested Amount
Est. Return
Total Value
rated by Value Research
Your principal will be at Very High Risk
Absolute Returns
CAGR
Company Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | Healthcare | E | 9.49% |
| Ajanta Pharma Ltd | Healthcare | E | 5.84% |
| Lupin Ltd | Healthcare | E | 4.23% |
| Apollo Hospitals Enterprise Ltd | Healthcare | E | 3.54% |
| Divi's Laboratories Ltd | Healthcare | E | 3.45% |
| Glenmark Pharmaceuticals Ltd | Healthcare | E | 3.35% |
| Dr Reddy's Laboratories Ltd | Healthcare | E | 3.35% |
| Gland Pharma Ltd | Healthcare | E | 3.30% |
| Fortis Healthcare Ltd | Healthcare | E | 3.23% |
| Alkem Laboratories Ltd | Healthcare | E | 3.21% |
| Max Healthcare Institute Ltd Ordinary Shares | Healthcare | E | 3.00% |
| Cohance Lifesciences Ltd | Healthcare | E | 2.96% |
| Anthem Biosciences Ltd | Healthcare | E | 2.48% |
| Aurobindo Pharma Ltd | Healthcare | E | 2.46% |
| Procter & Gamble Health Ltd | Healthcare | E | 2.28% |
| Ipca Laboratories Ltd | Healthcare | E | 2.19% |
| Caplin Point Laboratories Ltd | Healthcare | E | 2.17% |
| Sai Life Sciences Ltd | Healthcare | E | 2.15% |
| Global Health Ltd | Healthcare | E | 2.06% |
| Sudeep Pharma Ltd | Healthcare | E | 1.99% |
| Aster DM Healthcare Ltd Ordinary Shares | Healthcare | E | 1.99% |
| Viyash Scientific Ltd | Healthcare | E | 1.95% |
| Jupiter Life Line Hospitals Ltd | Healthcare | E | 1.94% |
| Marksans Pharma Ltd | Healthcare | E | 1.83% |
| Cipla Ltd | Healthcare | E | 1.72% |
| Metropolis Healthcare Ltd | Healthcare | E | 1.61% |
| Rainbow Childrens Medicare Ltd | Healthcare | E | 1.58% |
| Eris Lifesciences Ltd Registered Shs | Healthcare | E | 1.56% |
| Pfizer Ltd | Healthcare | E | 1.47% |
| Krishna Institute of Medical Sciences Ltd | Healthcare | E | 1.34% |
| Vijaya Diagnostic Centre Ltd | Healthcare | E | 1.31% |
| Windlas Biotech Ltd | Healthcare | E | 1.23% |
| Dr. Lal PathLabs Ltd | Healthcare | E | 1.20% |
| Emcure Pharmaceuticals Ltd | Healthcare | E | 1.02% |
| Sanofi Consumer Healthcare India Ltd | Healthcare | E | 1.01% |
| Laxmi Dental Ltd | Healthcare | E | 0.98% |
| Aarti Pharmalabs Ltd | Healthcare | E | 0.97% |
| Jubilant Pharmova Ltd | Healthcare | E | 0.73% |
| Alembic Pharmaceuticals Ltd | Healthcare | E | 0.68% |
| Syngene International Ltd | Healthcare | E | 0.67% |
| Biocon Ltd | Healthcare | E | 0.63% |
| Acutaas Chemicals Ltd | Basic Materials | E | 0.57% |
| Orchid Pharma Ltd | Healthcare | E | 0.55% |
| Net Current Assets | - | C | 4.74% |
| Clearing Corporation Of India Ltd. Std - Margin | - | CR | 0.00787% |
Equity / Debt / Cash Split
Equity
95.25%
Cash
4.75%
Equity sector allocation
Basic Materials
0.57%
Healthcare
94.69%
Others
4.74%
Asset Management Company

Nippon India Taiwan Equity Reg Gr
Equity
Min. Investment
₹500
Category Returns
32.09%
63.78%
3Y Returns
+63.78%

Mirae Asset NYSE FANG+ ETF FoF Reg Gr
Equity
Min. Investment
₹5000
Category Returns
32.09%
63.78%
3Y Returns
+48.34%

DSP Wld Gld Mng Ovrs Eq Omni FoF Gr
Equity
Min. Investment
₹100
Category Returns
32.09%
63.78%
3Y Returns
+45.98%
Investment Objective of the Scheme
Key Features of The Fund
5-year return
+14.12%
Fund Manager
Kamal Gada
Risk Profile
Very High Risk
Expense Ratio
2.30%
Fund Size
₹1143.58 Cr
The UTI Healthcare Reg Gr has invested the majority of its money in the stocks of the following companies:
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceuticals Industries Ltd | 9.49% |
| Ajanta Pharma Ltd | 5.84% |
| Lupin Ltd | 4.23% |
| Apollo Hospitals Enterprise Ltd | 3.54% |
| Divi's Laboratories Ltd | 3.45% |
| Glenmark Pharmaceuticals Ltd | 3.35% |
| Dr Reddy's Laboratories Ltd | 3.35% |
| Gland Pharma Ltd | 3.30% |
| Fortis Healthcare Ltd | 3.23% |
| Alkem Laboratories Ltd | 3.21% |
| Max Healthcare Institute Ltd Ordinary Shares | 3.00% |
| Cohance Lifesciences Ltd | 2.96% |
| Anthem Biosciences Ltd | 2.48% |
| Aurobindo Pharma Ltd | 2.46% |
| Procter & Gamble Health Ltd | 2.28% |
| Ipca Laboratories Ltd | 2.19% |
| Caplin Point Laboratories Ltd | 2.17% |
| Sai Life Sciences Ltd | 2.15% |
| Global Health Ltd | 2.06% |
| Sudeep Pharma Ltd | 1.99% |
| Aster DM Healthcare Ltd Ordinary Shares | 1.99% |
| Viyash Scientific Ltd | 1.95% |
| Jupiter Life Line Hospitals Ltd | 1.94% |
| Marksans Pharma Ltd | 1.83% |
| Cipla Ltd | 1.72% |
| Metropolis Healthcare Ltd | 1.61% |
| Rainbow Childrens Medicare Ltd | 1.58% |
| Eris Lifesciences Ltd Registered Shs | 1.56% |
| Pfizer Ltd | 1.47% |
| Krishna Institute of Medical Sciences Ltd | 1.34% |
| Vijaya Diagnostic Centre Ltd | 1.31% |
| Windlas Biotech Ltd | 1.23% |
| Dr. Lal PathLabs Ltd | 1.20% |
| Emcure Pharmaceuticals Ltd | 1.02% |
| Sanofi Consumer Healthcare India Ltd | 1.01% |
| Laxmi Dental Ltd | 0.98% |
| Aarti Pharmalabs Ltd | 0.97% |
| Jubilant Pharmova Ltd | 0.73% |
| Alembic Pharmaceuticals Ltd | 0.68% |
| Syngene International Ltd | 0.67% |
| Biocon Ltd | 0.63% |
| Acutaas Chemicals Ltd | 0.57% |
| Orchid Pharma Ltd | 0.55% |
| Net Current Assets | 4.74% |
| Clearing Corporation Of India Ltd. Std - Margin | 0.01% |
The UTI Healthcare Reg Gr has invested the majority of its money in the stocks of the following sectors -
| Company | Percentage of Portfolio |
|---|---|
| Basic Materials | 0.57% |
| Communication Services | - |
| Consumer Cyclical | - |
| Consumer Defensive | - |
| Energy | - |
| Financial Services | - |
| Healthcare | 94.69% |
| Industrials | - |
| Real Estate | - |
| Technology | - |
| Utilities | - |
Investing in mutual funds is easy on HDFC SKY.
Follow these simple steps to invest in UTI Healthcare Reg Gr:
The exit load of UTI Healthcare Reg Gr is as follows:
Exit load of 1.0%, if redeemed within 1 year
.The following are the Steps to Redeem mutual funds on HDFC SKY:
1. Go to Mutual Funds > My Investments/Portfolio.
2. Select the fund and tap Redeem/Sell.
3. Choose Full, Units, or Amount.
4. Review NAV, units, and exit load.
5. Confirm. Amount (Units × NAV) is credited to the registered bank in T+1–T+3 days. ELSS has a 3-year lock-in.
By signing up I certify terms, conditions & privacy policy